Kinross KGC Q1 2026 Results Fall Short EPS 071 Revenue NA UHaul UHAL Slides 201 as Selling Pressure Mounts 20260515 Market Update HWM CSCO ITRI VLO XYL GEHC Key Stock Movers in Focus Renters Insurance Costs What Tenants Need to Know in 2026 Nvidia Stock Slips After Earnings Release Why LongTerm Investors Might Look Past the Volatility SpaceX Scrubs Starship Test Flight Schedules Retry for Friday as IPO Plans Advance Surging Gasoline Costs Force Americans to Tap Emergency Savings Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth USChina Trade Rifts Persist at APEC Despite TrumpXi Summit Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives XCF Global Inc SAFX Q1 2026 Earnings Narrower Loss Surprise Drives Stock Gains ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline Tsakos Energy Navigation TEN Q1 2026 Earnings EPS Surges Past Estimates by 37 Despite Revenue Uncertainty MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower PCG Q1 2026 Earnings EPS Beats Estimates by 187 as Utility Navigates Regulatory Landscape BCRX Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction Merit Medical Systems MMSI Edges Higher Testing Resistance Near 68 Janus Living Inc JAN Holds Steady Near 2672 as Narrow Range Trading Persists Payoneer Global Faces Mild Pressure Holds Above Key Support Willow Lane Acquisition Corp Unit WLACU Surges 77 as SPAC Unit Breaks Out Lantheus Holdings LNTH Surges 9 Key Levels and Momentum Drivers Odysightai Q1 2026 Earnings EPS Misses Estimates Stock Declines Titan Machinery Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Evaxion AS EVAX Q1 2026 Earnings Pipeline Progress Tempered by WiderThanExpected Loss DNOW Q1 2026 Earnings Significant EPS Miss Highlights Profitability Challenges VLRS Q1 2026 Earnings Narrower Loss Beats Expectations But Stock Declines Tech Giants Pledge Up to 500 Billion for AI Infrastructure in US GLNG Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Drugs Made In America Acquisition Corp Rights DMAAR Edges Higher Analyzing the 012 Level